What is in the future for T-cell lymphoma?
Recently, PharmaMar announced the start of a phase 2 clinical trial to evaluate the efficacy of plitidepsin, a potential treatment option for adult patients with relapsed and refractory angioimmunoblastic T-cell lymphoma (AITL). In this VJHemOnc – ... Read more